Drug & supplement interaction

Tetrahydrocannabivarin (thcv) + Palivizumab

Palivizumab brand name: Synagis.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Tetrahydrocannabivarin (thcv) and Palivizumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Tetrahydrocannabivarin (thcv) and Palivizumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Palivizumab and Tetrahydrocannabivarin (thcv) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Tetrahydrocannabivarin (thcv) at all — not against Palivizumab, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Tetrahydrocannabivarin (thcv) safety at a glance

Tetrahydrocannabiv... overall Use caution Human safety data are limited, and product quality and legality vary a lot.
Pregnancy Avoid Cannabis-derived compounds are not considered safe in pregnancy.
Breastfeeding Avoid Cannabinoids can pass into breast milk, so avoid use while nursing.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Palivizumab and Tetrahydrocannabivarin (thcv)? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Palivizumab’s Own FDA Label Lists

This is not an interaction — none of it involves Tetrahydrocannabivarin (thcv). These are the most notable effects listed in the ADVERSE REACTIONS section of Palivizumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 3 of them are worth acting on rather than waiting out — marked below.

  • A low platelet count Worth acting on
  • A severe allergic reaction Worth acting on
  • An allergic reaction Worth acting on
  • Fever mentioned in 9.5% of FDA reports for Palivizumab
  • A skin rash

From the ADVERSE REACTIONS section of the FDA label for Palivizumab. Read the label on DailyMed › Where a percentage is shown, it is the share of 15,272 voluntary FDA FAERS reports for Palivizumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Tetrahydrocannabivarin (thcv)’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Tetrahydrocannabivarin (thcv) side to compare — that is a limit of the record, not a statement that Tetrahydrocannabivarin (thcv) has no side effects.

Everything else you take

See Every Supplement That Interacts With Palivizumab

This page covers Tetrahydrocannabivarin (thcv) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Palivizumab page lists 53 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Active Hexose Correlated Compound (ahcc) (moderate), Alfalfa (moderate), American Ginseng (moderate), Andrographis (moderate) and Ashwagandha (moderate).

By severity: 52 moderate · 1 minor.

From our pharmacist’s overview on the Palivizumab page

“Everything on this list for palivizumab (Synagis), the antibody injection given monthly to shield premature and other high-risk infants from RSV, points in one direction. These are supplements that stimulate the immune system, and stimulating the immune system could in theory work against a medicine that acts on it.”

Reviewed by 2 · Jul 18, 2026

Open the Palivizumab interaction page

How much people look this up

Where Tetrahydrocannabivarin (thcv) and Palivizumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Tetrahydrocannabivarin (thcv)
Steady interest

#1,004 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Palivizumab
Steady interest

#2,227 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Tetrahydrocannabivarin (thcv) is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Tetrahydrocannabivarin (thcv) reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified October 4, 2026. The Tetrahydrocannabivarin (thcv) and Palivizumab records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Tetrahydrocannabivarin (thcv)

What is Tetrahydrocannabivarin (thcv)?

  • Appetite control and weight management
  • Blood sugar support
  • Energy and focus
  • General wellness

Tetrahydrocannabivarin (THCV) is a minor cannabinoid found in cannabis that is being studied for appetite, metabolism, and blood sugar, but human evidence is very limited. Product quality, legal status, and dosing vary widely, so talk with your pharmacist or doctor before trying it, and avoid it during pregnancy and breastfeeding.

Cannabis sativa · Cannabaceae · Flowers and leaves of the cannabis plant (THCV is an extracted or isolated cannabinoid) · Oils, tinctures, capsules, gummies, vape products, and isolated extracts

An interaction check asks whether these two react with each other — it does not ask whether Tetrahydrocannabivarin (thcv) is a good idea for someone in your situation. Here is what our Tetrahydrocannabivarin (thcv) record says about it on its own.

Tetrahydrocannabivarin (thcv): dosing

There is no established standard dose for THCV. Research is too limited to recommend a specific milligram amount, and effects may even differ between low and high doses.If you choose to try a product, follow the directions on the label and start with the lowest amount.

From our Tetrahydrocannabivarin (thcv) monograph — the full record covers uses, side effects and every documented interaction.

Read the full Tetrahydrocannabivarin (thcv) monograph & all interactions
Medication

About Palivizumab Injection

What Is Palivizumab Injection Used For?

Brand name: Synagis

Palivizumab Injection (Synagis) helps prevent serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in certain children. Lower respiratory tract disease means infection in the lungs and lower airways.

It is not a treatment for RSV once a child is sick. Safety and effectiveness for treating RSV disease have not been established.

Most-Reported Side Effects for Palivizumab

From FAERS, the FDA’s public side-effect reporting system (15,272 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Respiratory syncytial virus infection 2,105 reports
Fever 1,450 reports
Bronchiolitis 1,274 reports
Cough 1,028 reports
Pneumonia 948 reports
See full Palivizumab Injection drug information
Keep checking

Other Drugs & Tetrahydrocannabivarin (thcv)

Browse every other medication we’ve checked against Tetrahydrocannabivarin (thcv) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Tetrahydrocannabivarin (thcv) References

The 2 sources that drive our Tetrahydrocannabivarin (thcv) monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Tetrahydrocannabivarin (thcv) is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Cannabis (Marijuana) and Cannabinoids: What You Need To Know — NIH NCCIH Source
  2. Marijuana — MedlinePlus Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Tetrahydrocannabivarin (thcv) and Palivizumab Together: Common Questions

Is it safe to take Tetrahydrocannabivarin (thcv) with Palivizumab?
We do not list a known interaction between Tetrahydrocannabivarin (thcv) and Palivizumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does Palivizumab interact with any supplements?
Yes. Palivizumab has documented interactions with 53 supplements in our database — Tetrahydrocannabivarin (thcv) is not one of them. The Palivizumab interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Palivizumab and Tetrahydrocannabivarin (thcv)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.